Apollo Hospitals Enterprise Ltd.
APOLLOHOSP · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹2,768.17.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%21.5%
- ✕Low debt (D/E < 0.5)0.85x
- ✓Positive free cash flow
- ✓Revenue growth > 10%18%
- ✓Earnings growing36%
- ✕Net margin ≥ 10%7.7%
- ✕Current ratio > 1.51.06
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 7.39
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Strong return on equity (21.5%).
- •Trading near its 52-week high.
- •Financially solid — Altman Z 7.39.
Opportunities
- •Earnings growing (36% YoY).
- •Revenue growing (18% YoY).
Threats
- •Rich valuation versus sector peers.
- •Trades ~59% above our estimated fair value.
About Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.